Cargando…
Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
The incidence of dementia is increasing at an alarming rate, and has become a major public health concern. Alzheimer disease (AD) is the most common form of dementia and is characterized by progressive cognitive impairment. In addition to classical neuropathological features such as amyloid plaques...
Autores principales: | Takeda, Shuko, Sato, Naoyuki, Morishita, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114193/ https://www.ncbi.nlm.nih.gov/pubmed/25120476 http://dx.doi.org/10.3389/fnagi.2014.00171 |
Ejemplares similares
-
Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors
por: Sato, Naoyuki, et al.
Publicado: (2013) -
The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease
por: Sato, Naoyuki, et al.
Publicado: (2015) -
Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors
por: Shinohara, Mitsuru, et al.
Publicado: (2014) -
Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
por: Ott, Brian R., et al.
Publicado: (2018) -
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
por: Zotova, Elina, et al.
Publicado: (2010)